Nitric oxide attenuates beryllium-induced IFNgamma responses in chronic beryllium disease: evidence for mechanisms independent of IL-18
- PMID: 12027422
- DOI: 10.1006/clim.2002.5211
Nitric oxide attenuates beryllium-induced IFNgamma responses in chronic beryllium disease: evidence for mechanisms independent of IL-18
Abstract
In chronic beryllium disease (CBD), a granulomatous lung disease characterized by hypersensitivity to beryllium salts (BE), BE challenge of bronchoalveolar lavage cells induces IFNgamma. Although nitric oxide (NO) is elevated in CBD airways, the effects of NO on CBD IFNgamma responses are unknown. Here we report that BE-stimulated IFNgamma production in CBD lavage cells was markedly reduced (74%) by the NO generator DETA NONOate. Investigation of IFNgamma-stimulatory cytokine involvement indicated that lavage cell IL-18 was significantly increased (fourfold) by BE and reduced (64%) by DETA NONOate but IL-12 was undetectable. IL-18 production was caspase-1-dependent but caspase 1 inhibition reduced IFNgamma only partially (43%). Specific antibody depletion of lavage cell IL-18 yielded marginal reduction (19%) of IFNgamma. Data are the first to show that: (1) BE stimulates IL-18 as well as IFNgamma in CBD; (2) BE cytokine responses are NO-sensitive; and (3) NO down-regulation of IFNgamma involves other sites in addition to IL-18.
(c) 2002 Elsevier Science (USA).
Similar articles
-
Beryllium induces IL-2 and IFN-gamma in berylliosis.J Immunol. 1997 Jan 1;158(1):518-26. J Immunol. 1997. PMID: 8977230
-
Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.J Immunol. 1999 Sep 1;163(5):2747-53. J Immunol. 1999. PMID: 10453017
-
IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis.Eur Respir J. 2001 Mar;17(3):403-15. doi: 10.1183/09031936.01.17304030. Eur Respir J. 2001. PMID: 11405518
-
Chronic beryllium disease: a hypersensitivity disorder.Appl Occup Environ Hyg. 2001 May;16(5):615-8. doi: 10.1080/10473220121477. Appl Occup Environ Hyg. 2001. PMID: 11370939 Review.
-
Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.Trends Immunol. 2005 Oct;26(10):543-9. doi: 10.1016/j.it.2005.08.004. Trends Immunol. 2005. PMID: 16099719 Review.
Cited by
-
Chronic beryllium disease: an updated model interaction between innate and acquired immunity.Biometals. 2011 Feb;24(1):1-17. doi: 10.1007/s10534-010-9376-3. Epub 2010 Oct 28. Biometals. 2011. PMID: 20981472 Free PMC article. Review.
-
Clinical application of beryllium lymphocyte proliferation testing.Clin Diagn Lab Immunol. 2003 Nov;10(6):990-4. doi: 10.1128/cdli.10.6.990-994.2003. Clin Diagn Lab Immunol. 2003. PMID: 14607857 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous